BRENTUXIMAB VEDONTIN FOR SKIN INVOLVEMENT IN REFRACTORY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, INTERIM RESULTS OF A PHASE IIB OPEN-LABEL TRIAL

被引：7
|
作者：
Fernandez-Codina, A. [1 ,2 ,3 ]
Nevskaya, T. [1 ]
Pope, J. [1 ]
机构：
[1] Western Univ, Div Rheumatol, Med, London, ON, Canada
[2] Windsor Reg Hosp Ouellette Campus, Med, Windsor, ON, Canada
[3] Hosp Clin Barcelona, Syst Autoimmune Dis, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.2115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0172
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [41] Dose Escalation Safety Study of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis:Clinical Results and Mechanistic Analysis of Skin and Peripheral Blood Mononuclear Cells
    Fox, David
    Cooney, Laura
    Stelzig, Lia
    Lafyatis, Robert
    Gudjonsson, Johann
    Tsoi, Lam
    Mayes, Maureen
    Shah, Ankoor
    Kafaja, Suzanne
    Barry, William
    Goldmuntz, Ellen
    Smilek, Dawn
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5445 - 5447
  • [42] Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
    Distler, Oliver
    Allanore, Yannick
    Denton, Christopher P.
    Kuwana, Masataka
    Matucci-Cerinic, Marco
    Pope, Janet E.
    Atsumi, Tatsuya
    Becvar, Radim
    Czirjak, Laszlo
    Hachulla, Eric
    Ishii, Tomonori
    Ishikawa, Osamu
    Johnson, Sindhu R.
    De Langhe, Ellen
    Stagnaro, Chiara
    Riccieri, Valeria
    Schiopu, Elena
    Silver, Richard M.
    Smith, Vanessa
    Steen, Virginia
    Stevens, Wendy
    Szuecs, Gabriella
    Truchetet, Marie-Elise
    Wosnitza, Melanie
    Laapas, Kaisa
    Kramer, Frank
    Khanna, Dinesh
    LANCET RHEUMATOLOGY, 2023, 5 (11): : E660 - E669
  • [43] ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS - A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL
    Gopaluni, Seerapani
    Goymer, Donna
    McClure, Mark
    Cahill, Hugh
    Broadhurst, Elizabeth
    Smith, Rona
    Jayne, David
    RHEUMATOLOGY, 2019, 58
  • [44] Phase IIa trial of imatinib mesylate (Gleevec) in the treatment of diffuse systemic sclerosis - An interim analysis
    Spiera, Robert F.
    Gordon, Jessica K.
    Mehta, Mansi
    Kirou, Kyriakos A.
    Lyman, Stephen
    Kloiber, Stacey A.
    Crow, Mary K.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S623 - S623
  • [45] Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
    Dimopoulos, Meletios A.
    Goldschmidt, Hartmut
    Niesvizky, Ruben
    Joshua, Douglas
    Chng, Wee-Joo
    Oriol, Albert
    Orlowski, Robert Z.
    Ludwig, Heinz
    Facon, Thierry
    Hajek, Roman
    Weisel, Katja
    Hungria, Vania
    Minuk, Leonard
    Feng, Shibao
    Zahlten-Kumeli, Anita
    Kimball, Amy S.
    Moreau, Philippe
    LANCET ONCOLOGY, 2017, 18 (10): : 1327 - 1337
  • [46] Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
    Laroni, A.
    Brogi, D.
    Morra, V. Brescia
    Guidi, L.
    Pozzilli, C.
    Comi, G.
    Lugaresi, A.
    Turrini, R.
    Raimondi, D.
    Uccelli, A.
    Mancardi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 509 - 510
  • [47] Safety and Efficacy of Anabasum (JBT-101) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Subjects Treated in an Open-Label Extension of Trial JBT101-SSc-001
    Spiera, Robert F.
    Hummers, Laura K.
    Chung, Lorinda
    Frech, Tracy M.
    Domsic, Robyn T.
    Hsu, Vivien
    Furst, Daniel E.
    Gordon, Jessica K.
    Mayes, Maureen D.
    Simms, Robert W.
    Constantine, Scott
    White, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [48] Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
    Laroni, Alice
    Brogi, Davide
    Morra, Vincenzo Brescia
    Guidi, Leonello
    Pozzilli, Carlo
    Comi, Giancarlo
    Lugaresi, Alessandra
    Turrini, Renato
    Raimondi, Debora
    Uccelli, Antonio
    Mancardi, Giovanni Luigi
    BMC NEUROLOGY, 2014, 14
  • [49] Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
    Alice Laroni
    Davide Brogi
    Vincenzo Brescia Morra
    Leonello Guidi
    Carlo Pozzilli
    Giancarlo Comi
    Alessandra Lugaresi
    Renato Turrini
    Debora Raimondi
    Antonio Uccelli
    Giovanni Luigi Mancardi
    BMC Neurology, 14
  • [50] Interim Analyses from the Beacon Trial: A Phase 2, Randomized, Open-Label Trial of Bitopertin in Erythropoietic Protoporphyria
    Ross, Gayle
    Stewart, Peter
    Mensing, George
    Chin, Melanie
    Howell, Haley
    Mangus, Heidi
    Savage, William
    BLOOD, 2023, 142
12345